AZ to Focus on Asthma-COPD Overlap in Marketing Triple-Combo Therapy Breztri, Will Help GPs Make Diagnosis

Arne Dirks, Vice President, Respiratory Business Unit of AZ Japan The Japan arm of AstraZeneca plans to market its new triple-combination COPD therapy Breztri (budesonide + glycopyrronium + formoterol fumarate), which it launched earlier this month, with a special focus...read more